Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma.
about
Contribution of transcription factor, SP1, to the promotion of HB-EGF expression in defense mechanism against the treatment of irinotecan in ovarian clear cell carcinoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Contribution of transcription ...... ovarian clear cell carcinoma.
@ast
Contribution of transcription ...... ovarian clear cell carcinoma.
@en
Contribution of transcription ...... ovarian clear cell carcinoma.
@nl
type
label
Contribution of transcription ...... ovarian clear cell carcinoma.
@ast
Contribution of transcription ...... ovarian clear cell carcinoma.
@en
Contribution of transcription ...... ovarian clear cell carcinoma.
@nl
prefLabel
Contribution of transcription ...... ovarian clear cell carcinoma.
@ast
Contribution of transcription ...... ovarian clear cell carcinoma.
@en
Contribution of transcription ...... ovarian clear cell carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Contribution of transcription ...... n ovarian clear cell carcinoma
@en
P2093
Fusanori Yotsumoto
Hiroaki Itamochi
Hiroshi Asahara
Junzo Kigawa
Masahide Kuroki
Sadao Manabe
Shingo Miyamoto
Shuji Takada
Sung Ouk Nam
Takashi Odawara
P2860
P304
P356
10.1002/CAM4.301
P407
P50
P577
2014-07-24T00:00:00Z